POM-V Prescription Required

Porcilis APP Suspension for Injection

Active ingredient: Actinobacillus pleuropneumoniae

Form

Injection

Species

Pigs

Manufacturer

Intervet International B.V.

VMD MA No.

06376/3030

What it's used for

Onset of immunity: 2 weeks after completion of the vaccination scheme. Duration of immunity: 11 weeks after completion of the vaccination scheme.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Actinobacillus pleuropneumon...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Porcilis APP Suspension for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: 2 weeks after completion of the vaccination scheme.
Duration of immunity: 11 weeks after completion of the vaccination scheme.

Route of administration: Deep intramuscular injection.
Allow the vaccine to reach ambient temperature (between 15 °C to 25 °C) before
use.
Shake bottle vigorously before and at intervals during use.
Clean and sterile vaccination equipment should be used.
The use of automatic vaccination equipment is recommended.
Maximum protection should be achieved before the start of the fattening period.
Pigs may be vaccinated from 6 weeks of age.
Two doses at least 4 weeks apart are required. It is advised to give these at 6 and 10
weeks of age.

None.

Pigs (weaned piglets):
Very common
(>1 animal / 10 animals
treated):
Injection site reaction
;
Anorexia, Decreased activity, Depression
Common
(1 to 10 animals / 100 animals
treated):
Elevated temperature
2,3
; Decreased appetite
Increased respiratory rate
3,4
;
Vomiting
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylaxis
These are mild to moderate reactions, that resolve within 5 days post-vaccination.
Increases up to 2 °C.
Resolve within 24 hours after vaccination.
With a change towards abdominal breathing and dyspnoea.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
It is not advisable to vaccinate animals immediately before and after feeding.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection or ingestion, seek medical advice immediately and
show the
package leaflet or the label to the physician. If spilled on the skin, wash with soap
and water.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.

Store in a refrigerator (2 °C – 8 °C).
Do not freeze.
Protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.